84 related articles for article (PubMed ID: 15780553)
21. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB
J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938
[TBL] [Abstract][Full Text] [Related]
22. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
Liu T; Liu PY; Tee AE; Haber M; Norris MD; Gleave ME; Marshall GM
Eur J Cancer; 2009 Jul; 45(10):1846-54. PubMed ID: 19342222
[TBL] [Abstract][Full Text] [Related]
23. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
Iakhiaev AV; Rezaie AR; Idell S
Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
[TBL] [Abstract][Full Text] [Related]
24. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology.
Winter PC
Hematol Oncol; 2006 Sep; 24(3):126-33. PubMed ID: 16783843
[TBL] [Abstract][Full Text] [Related]
25. Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival.
Hanly AM; Redmond M; Winter DC; Brophy S; Deasy JM; Bouchier-Hayes DJ; Kay EW
Br J Cancer; 2006 May; 94(9):1320-5. PubMed ID: 16622452
[TBL] [Abstract][Full Text] [Related]
26. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
Patiar S; Harris AL
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2.
Tuomisto TT; Lumivuori H; Kansanen E; Häkkinen SK; Turunen MP; van Thienen JV; Horrevoets AJ; Levonen AL; Ylä-Herttuala S
Cardiovasc Res; 2008 Apr; 78(1):175-84. PubMed ID: 18192240
[TBL] [Abstract][Full Text] [Related]
28. Statins and the endothelium.
Ii M; Losordo DW
Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
[TBL] [Abstract][Full Text] [Related]
29. Focal adhesion kinase: a potential target in cancer therapy.
van Nimwegen MJ; van de Water B
Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
[TBL] [Abstract][Full Text] [Related]
30. Statins, stem cells, and cancer.
Gauthaman K; Fong CY; Bongso A
J Cell Biochem; 2009 Apr; 106(6):975-83. PubMed ID: 19224538
[TBL] [Abstract][Full Text] [Related]
31. Telomere biology of pediatric cancer.
Tabori U; Dome JS
Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
[TBL] [Abstract][Full Text] [Related]
33. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
34. A subcloned human esophageal squamous cell carcinoma cell line with low thrombomodulin expression showed increased invasiveness compared with a high thrombomodulin-expressing clone--thrombomodulin as a possible candidate for an adhesion molecule of squamous cell carcinoma.
Matsushita Y; Yoshiie K; Imamura Y; Ogawa H; Imamura H; Takao S; Yonezawa S; Aikou T; Maruyama I; Sato E
Cancer Lett; 1998 May; 127(1-2):195-201. PubMed ID: 9619877
[TBL] [Abstract][Full Text] [Related]
35. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
36. Statins downregulate myeloperoxidase gene expression in macrophages.
Kumar AP; Reynolds WF
Biochem Biophys Res Commun; 2005 Jun; 331(2):442-51. PubMed ID: 15850779
[TBL] [Abstract][Full Text] [Related]
37. Influence of pentoxifylline on membrane thrombomodulin levels in endothelial cells submitted to hypoxic conditions.
Seigneur M; Dufourcq P; Belloc F; Lenoble M; Renard M; Boisseau MR
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S85-7. PubMed ID: 8699869
[TBL] [Abstract][Full Text] [Related]
38. Expression of the endothelial thrombomodulin (TM) on the ischemic rat flap model: preliminary study.
Uygur F; Noyan N; Celiköz B; Hahaoğlu A
Ann Plast Surg; 2009 Jun; 62(6):693-8. PubMed ID: 19461288
[TBL] [Abstract][Full Text] [Related]
39. Mouse monoclonal anti-human thrombomodulin antibodies bind to and activate endothelial cells through NF-kappaB activation in vitro.
Nara H; Okamoto H; Minota S; Yoshio T
Arthritis Rheum; 2006 May; 54(5):1629-37. PubMed ID: 16646025
[TBL] [Abstract][Full Text] [Related]
40. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas.
Li J; Tan H; Dong X; Xu Z; Shi C; Han X; Jiang H; Krissansen GW; Sun X
Dig Liver Dis; 2007 Jun; 39(6):557-65. PubMed ID: 17374519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
